menu
    • menu

    Company profile for Oncotelic Therapeutics

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Oncotelic is an immuno-oncology company dedicated to the development of first in class RNA therapeutics as well as small molecule drugs against cancer and infectious diseases. OT-101, the lead immuno-oncology drug candidate of Oncotelic, is a first-in-class anti-TGF-βRNA therapeutic that exhibited single agent activity in relapsed/refractory cancer patients in clinical trial settings. OT-101 also has activity against SARS-CoV...
    Oncotelic is an immuno-oncology company dedicated to the development of first in class RNA therapeutics as well as small molecule drugs against cancer and infectious diseases. OT-101, the lead immuno-oncology drug candidate of Oncotelic, is a first-in-class anti-TGF-βRNA therapeutic that exhibited single agent activity in relapsed/refractory cancer patients in clinical trial settings. OT-101 also has activity against SARS-CoV-2. Mateon/Oncotelic is seeking to leverage its deep expertise in drug development to improve treatment outcomes and survival of cancer patients with a special emphasis on rare pediatric cancers.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Oncotelic TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    29397 Agoura road, Suite 107, Agoura hills CA 91301
    Telephone
    Telephone
    6506357000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.oncotelic.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/oncotelic/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Oncotelic

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Oncotelic Therapeutics & Brush & Key Publish Paper in IJMS
    Oncotelic Therapeutics & Brush & Key Publish Paper in IJMS

    15 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/15/3205570/0/en/Oncotelic-Therapeutics-and-Brush-and-Key-Foundation-Announce-Publication-in-International-Journal-of-Molecular-Sciences-Highlighting-Context-Dependent-Biomarkers-in-Liver-and-Pancr.html

    GLOBENEWSWIRE
    15 Dec 2025
    Share Share
    Oncotelic, Sapu Nano Unveil Deciparticle-Led Cancer Biomarker
    Oncotelic, Sapu Nano Unveil Deciparticle-Led Cancer Biomarker

    04 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/04/3199970/0/en/Oncotelic-and-Sapu-Nano-Announce-DeciparticleTM-Led-Biomarker-Framework-Identifying-Tumors-Most-Likely-to-Respond-to-IV-Sapu003-an-Intravenous-Everolimus-Nanomedicine.html

    GLOBENEWSWIRE
    04 Dec 2025
    Share Share
    IV Sapu003 Shows 67x Lower GI Exposure vs Oral Everolimus
    IV Sapu003 Shows 67x Lower GI Exposure vs Oral Everolimus

    03 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/03/3198954/0/en/Oncotelic-and-Sapu-Nano-Announces-New-PK-Data-Demonstrating-IV-Sapu003-Reduces-GI-Accumulation-of-Everolimus-up-to-67-Fold-Compared-With-Oral-Dosing.html

    GLOBENEWSWIRE
    03 Dec 2025
    Share Share
    Oncotelic, Sapu Nano Introduce Versatile Deciparticle
    Oncotelic, Sapu Nano Introduce Versatile Deciparticle

    02 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/02/3197836/0/en/Oncotelic-and-Sapu-Nano-Unveils-Broad-Applicability-Deciparticle-Nanomedicine-Platform-Capable-of-Formulating-Multiple-Hydrophobic-Peptide-Macrolide-and-Polyketide-Drugs.html

    GLOBENEWSWIRE
    02 Dec 2025
    Share Share
    Oncotelic Expects Significant Value Increase Post JV Valuation
    Oncotelic Expects Significant Value Increase Post JV Valuation

    25 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/25/3194333/0/en/Oncotelic-Therapeutics-Inc-OTCQB-OTLC-Anticipates-Major-Fair-Value-Uptick-Following-New-Independent-JV-Valuation.html

    GLOBENEWSWIRE
    25 Nov 2025
    Share Share
    Oncotelic Therapeutics Emerges As Leader With Independent JV
    Oncotelic Therapeutics Emerges As Leader With Independent JV

    21 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/21/3192789/0/en/Oncotelic-Therapeutics-Inc-OTCQB-OTLC-Emerging-as-Leader-with-New-Independent-JV-Valuation.html

    GLOBENEWSWIRE
    21 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search